JENNIFER O'BRIEN: Open Payments
NPI 1770125833 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 25 payments from 10 companies in 2025. Trend: 2023 $73 · 2024 $262 · 2025 $881
Food & beverage: $881
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $329 |
| Neurocrine BioSciences, Inc. | 9 | $265 |
| Teva Pharmaceuticals USA, Inc. | 4 | $125 |
| Axsome Therapeutics, Inc. | 1 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Alkermes, Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: INGREZZA, COBENFY, OPDIVO, AUSTEDO XR, Auvelity, CAPLYTA, UZEDY, REXULTI.
Industry payments across NJ — which companies pay providers there.
